Pre-commercial and newly commercialized life sciences companies can have the advantage of starting with a cloud-first digital approach on their lifecycle journey.
It can be challenging to move all your processes to the cloud with the many types of regulated content and data in your organization. In this on-demand webinar, we guide you through where startup and emerging life sciences companies can begin their transformation, and share insights on which cloud technologies can be scaled for GxP uses as your business grows.
What you'll learn
- Where startup and emerging life sciences companies should begin a cloud-first content management transformation.
- How content management workflows integrate with other systems and business functions across both regulated and non-regulated content.
- How to approach vendor selection, including an overview of content management vendors and a vendor selection process.
- How to integrate eSignature and other workflows while ensuring end-to-end GxP compliance in the public cloud.
- Common implementation and validation mistakes to avoid as you scale.
What the session covers
The discussion included:
- Content management workflows and the ability to integrate with other systems and business functions (regulated and non-regulated content)
- Overview of content management vendors
- Vendor selection process guidance
- Integration of eSignature and other workflows
- How to ensure end-to-end GxP compliance in the public cloud
- Common implementation and validation mistakes
- Live Q&A
USDM's point of view: Emerging life sciences companies don't carry the legacy of on-premise systems, which means they can build a cloud-first, GxP-ready foundation from day one instead of retrofitting compliance later. The advantage is real, but only if the content management platform, integrations, and validation approach are chosen with growth and regulatory expectations in mind. Getting software assurance, eSignature workflows, and data integrity right early prevents the costly rework that slows companies down as they move toward commercialization.
The presenters
Hovsep Kirikian, Project Manager, USDM Life Sciences
Erin Christy, Vice President of Emerging Life Sciences, USDM Life Sciences
Frequently asked questions
Why is a cloud-first approach an advantage for emerging life sciences companies?
Pre-commercial and newly commercialized companies typically don't carry legacy on-premise systems, so they can start their lifecycle journey with a cloud-first digital approach. That lets them adopt scalable cloud technologies for GxP uses from the outset rather than migrating and revalidating established systems later.
Where should a startup or emerging company begin its content management transformation?
The webinar guides you through where to begin and which cloud technologies can be scaled for GxP uses as the business grows, covering content management workflows and how they integrate with other regulated and non-regulated systems and business functions.
How do you ensure GxP compliance when content lives in the public cloud?
Ensuring end-to-end GxP compliance in the public cloud is a core topic of the session, alongside the integration of eSignature and other workflows. A disciplined, risk-based validation approach such as Computer Software Assurance (CSA) and ongoing cloud assurance help keep validated systems compliant as vendors release updates.
How should we approach content management vendor selection?
The webinar includes an overview of content management vendors and guidance on the vendor selection process, so you can match a platform to your regulated and non-regulated content needs and your integration requirements.
What are common mistakes to avoid?
The session covers common implementation and validation mistakes that emerging companies make, helping you avoid the missteps that create compliance gaps or slow down scaling.
Watch the on-demand webinar
Watch this on-demand session to see where emerging life sciences companies can begin their cloud content management journey and how to scale GxP-compliant technologies as you grow. To discuss your own content management and validation roadmap with our team, contact USDM Life Sciences.